These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 8890400)

  • 21. [Expression of calbindin-D28k in genetic hypercalciuric stone-forming rats kidney and its role in pathogenesis of idiopathic hypercalciuria].
    Wang SG; Hu DL; Xi QL; Bai J; Su SQ; Yu X; Liu JH; Ye ZQ
    Zhonghua Yi Xue Za Zhi; 2008 May; 88(20):1422-4. PubMed ID: 18953885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Idiopathic hypercalciuria--recent pathogenetic and diagnostic aspects].
    Hess B; Binswanger U
    Schweiz Med Wochenschr; 1986 Nov; 116(45):1569-75. PubMed ID: 3538383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Persistence of 1,25D-induced hypercalciuria in alendronate-treated genetic hypercalciuric stone-forming rats fed a low-calcium diet.
    Frick KK; Asplin JR; Culbertson CD; Granja I; Krieger NS; Bushinsky DA
    Am J Physiol Renal Physiol; 2014 May; 306(9):F1081-7. PubMed ID: 24573387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urinary risk factors for recurrent calcium stone formation in Thai stone formers.
    Stitchantrakul W; Kochakarn W; Ruangraksa C; Domrongkitchaiporn S
    J Med Assoc Thai; 2007 Apr; 90(4):688-98. PubMed ID: 17487123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of cinacalcet on urine calcium excretion and supersaturation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Laplante K; Asplin JR
    Kidney Int; 2006 May; 69(9):1586-92. PubMed ID: 16557225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polymorphism of vitamin D receptor gene start codon in patients with calcium kidney stones.
    Vezzoli G; Soldati L; Proverbio MC; Adamo D; Rubinacci A; Bianchi G; Mora S
    J Nephrol; 2002; 15(2):158-64. PubMed ID: 12018632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative trait loci for hypercalciuria in a rat model of kidney stone disease.
    Hoopes RR; Reid R; Sen S; Szpirer C; Dixon P; Pannett AA; Thakker RV; Bushinsky DA; Scheinman SJ
    J Am Soc Nephrol; 2003 Jul; 14(7):1844-50. PubMed ID: 12819244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and laboratory characteristics of calcium stone-formers with and without primary hyperparathyroidism.
    Parks JH; Coe FL; Evan AP; Worcester EM
    BJU Int; 2009 Mar; 103(5):670-8. PubMed ID: 18793297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The idiopathic hypercalciuria reviewed. Metabolic abnormality or disease?
    García Nieto VM; Luis Yanes MI; Tejera Carreño P; Perez Suarez G; Moraleda Mesa T
    Nefrologia (Engl Ed); 2019; 39(6):592-602. PubMed ID: 31160051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A study of the etiology of idiopathic calcium urolithiasis in children: hypocitruria is the most important risk factor.
    Tekin A; Tekgul S; Atsu N; Sahin A; Ozen H; Bakkaloglu M
    J Urol; 2000 Jul; 164(1):162-5. PubMed ID: 10840454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone mass loss in calcium stone disease: focus on hypercalciuria and metabolic factors.
    Caudarella R; Vescini F; Buffa A; Sinicropi G; Rizzoli E; La Manna G; Stefoni S
    J Nephrol; 2003; 16(2):260-6. PubMed ID: 12768074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolation and confirmation of a calcium excretion quantitative trait locus on chromosome 1 in genetic hypercalciuric stone-forming congenic rats.
    Hoopes RR; Middleton FA; Sen S; Hueber PA; Reid R; Bushinsky DA; Scheinman SJ
    J Am Soc Nephrol; 2006 May; 17(5):1292-304. PubMed ID: 16611718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Defective renal calcium reabsorption in genetic hypercalciuric rats.
    Tsuruoka S; Bushinsky DA; Schwartz GJ
    Kidney Int; 1997 May; 51(5):1540-7. PubMed ID: 9150471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hypercalciuria and its consequences].
    Konopielko Z
    Pediatr Pol; 1996 Aug; 71(8):695-700. PubMed ID: 8927474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nephrolithiasis.
    Scheinman SJ
    Semin Nephrol; 1999 Jul; 19(4):381-8. PubMed ID: 10435676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of indapamide on urinary calcium excretion in patients with and without urinary stone disease.
    Ceylan K; Topal C; Erkoc R; Sayarlioglu H; Can S; Yilmaz Y; Dogan E; Algun E; Gonulalan H
    Ann Pharmacother; 2005 Jun; 39(6):1034-8. PubMed ID: 15840731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Functional evaluation in patients with kidney calculi].
    Stojimirović B
    Srp Arh Celok Lek; 1998; 126(9-10):394-8. PubMed ID: 9863414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atorvastatin inhibits renal crystal retention in a rat stone forming model.
    Tsujihata M; Momohara C; Yoshioka I; Tsujimura A; Nonomura N; Okuyama A
    J Urol; 2008 Nov; 180(5):2212-7. PubMed ID: 18804815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased biological response to 1,25(OH)(2)D(3) in genetic hypercalciuric stone-forming rats.
    Frick KK; Asplin JR; Favus MJ; Culbertson C; Krieger NS; Bushinsky DA
    Am J Physiol Renal Physiol; 2013 Mar; 304(6):F718-26. PubMed ID: 23344574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.